VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease
暂无分享，去创建一个
J. Bosq | J. Cosset | V. Ribrag | D. Decaudin | P. Carde | T. Girinsky | C. Corti | J. Pico | M. Hayat | J. Cosset | J. Munck | F. Nasr | J. Bouhris | P. Brault | J. Pico | JN Munck | JH Bouhris | JM Cosset | J. Munck